Back to results
US 2016/0257649 A1Published application
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
AssigneeShuttle Pharmaceuticals, Inc.
InventorsScott Grindrod, Mira Jung, Milton Brown, Anatoly Dritschilo
Life of this patent
Estimating the term…
Abstract
Dual function compounds are provided that may be inhibitors of histone deacetylase (HDAC) and activators of ataxia telangiectasia mutated (ATM). Pharmaceutical compositions and methods of use are also provided that utilize such compounds.
Claims46
A compound having the formula:
- wherein R1, R3, R7, and R8 are independently selected from the group consisting of H, hydroxy, halogen and, optionally substituted, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocycle, heteroaryl, amino, alkoxy, carboxy, carbalkoxy, carboxamido, sulfonyl, sulfinyl, monoalkylaminosulfinyl, dialkylaminosulfinyl, monoalkylaminosufonyl, dialkylaminosulfonyl, alkylsulfonylamino, hydroxysulfonyloxy, alkoxysulfonyloxy, alkylsulfonyloxy, hydroxysulfonyl, alkoxysulfonyl, alkylsulfonylalkyl, monoalkylaminosulfonylalkyl, dialkylaminosulfonylalkyl, monoalkylaminosulfinylalkyl, and dialkylaminosulfinylalkyl;
- R2 and R9 are independently selected from the group consisting of H and, optionally substituted, sulfinyl, sulfonyl, alkyl, alkenyl, cycloalkyl, aryl, heterocycle, and heteroaryl;
- R4 is selected from the group consisting of H and optionally substituted alkyl;
- R5 is selected from the group consisting of H, and optionally substituted alkyl and indole;
- R6 is selected from the group consisting of H and optionally substituted alkyl;
- X is selected from the group consisting of:
- wherein R10 is selected from the group consisting of H and, optionally substituted, alkyl, alkenyl, cycloalkyl, aryl, heterocycle, and heteroaryl;
- n is 0 or 1;
- r is an integer from 0 to 3;
- q is an integer from 3 to 10;
- the dashed line indicates the presence of a single bond or a double bond as allowed;
- with the proviso that, where X is a substituent other than maleimide or N-carbonylmaleimide and R5 is a substituent other than indole, then R3 is a substituent selected from the group consisting of hydroxy, halogen and, optionally substituted, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocycle, heteroaryl, amino, alkoxy, carboxy, carbalkoxy, carboxamido, sulfonyl, sulfinyl, monoalkylaminosulfinyl, dialkylaminosulfinyl, monoalkylaminosufonyl, dialkylaminosulfonyl, alkylsulfonylamino, hydroxysulfonyloxy, alkoxysulfonyloxy, alkylsulfonyloxy, hydroxysulfonyl, alkoxysulfonyl, alkylsulfonylalkyl, monoalkylaminosulfonylalkyl, dialkylaminosulfonylalkyl, monoalkylaminosulfinylalkyl, and dialkylaminosulfinylalkyl, with the dashed line indicating the presence of a double bond;
- and the pharmaceutically acceptable salts thereof.
10 more elements
Dependencies are inferred from the claim text.